- Citations, last 5 years
- 1
- Works, last 5 years
- 9
- h-index
- 2
- Scientists listed
- 0
- Grants since 2016
- 12
Grants received
2024 · grant
Pathways International US (2024)
Pathways Behavioral Services · funded by Open Society Foundations
2023–2025 · contract · N01
THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE
Barry Hart · Pathways Behavioral Services · funded by National Institutes of Health
2023–2024 · contract · N01
THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE
Barry Hart · Pathways Behavioral Services · funded by National Institutes of Health
2023–2026 · contract · N01
THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE
Barry Hart · Pathways Behavioral Services · funded by National Institutes of Health
2020–2023 · contract · N01
ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE
Barry Hart · Pathways Behavioral Services · funded by National Institutes of Health
2020–2021 · contract · N01
ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE
Barry Hart · Pathways Behavioral Services · funded by National Institutes of Health
2019–2020 · contract · N01
ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE
Barry Hart · Pathways Behavioral Services · funded by National Institutes of Health
2018–2019 · contract · N01
ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE
Barry Hart · Pathways Behavioral Services · funded by National Institutes of Health
2018–2023 · research · R43
Evaluation of IPW-5371, a TGFbRI kinase inhibitor, dosed as a single agent or in combination with G-CSF, as a medical countermeasure against the delayed effects of total body irradiation in mice
Barry P Hart · Pathways Behavioral Services · funded by National Institutes of Health
2018–2020 · research · R43
Evaluation of IPW-5371, a TGFbRI kinase inhibitor, dosed as a single agent or in combination with G-CSF, as a medical countermeasure against the delayed effects of total body irradiation in mice
Barry P Hart · Pathways Behavioral Services · funded by National Institutes of Health
2017–2018 · research · R43
A Topical Nrf2 Activator for Oral Mucositis
Brooks Michael Hybertson · Pathways Behavioral Services · funded by National Institutes of Health
2017–2018 · research · R43
Supporting Healthy Aging with a Phytochemical Combination that Acts at Multiple Control Points in the Nrf2 Activation Pathway
Brooks Michael Hybertson · Pathways Behavioral Services · funded by National Institutes of Health